Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
81
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in oxaliplatin-based chemotherapy

Xiaoyun Hu1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Wenyan Qin1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Shanqiong Li1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Miao He1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Yilin Wang1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Shu Guan2 Department of Breast Surgery, First Hospital of China Medical University, Shenyang 110001, China
,
Haishan Zhao1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Weifan Yao1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Minjie Wei1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]
,
Mingyan Liu1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
&
Huizhe Wu1 Department of Pharmacology, School of Pharmacy, Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China, [email protected]; [email protected]Correspondence[email protected] [email protected]
 show all
Pages 285-297 | Published online: 27 Dec 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alessia Bignucolo, Lucia Scarabel, Giuseppe Toffoli, Erika Cecchin & Elena De Mattia. (2022) Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers. Expert Review of Clinical Pharmacology 15:6, pages 689-713.
Read now

Articles from other publishers (11)

Maria Pagoni, Claudia Cava, Diamantis C. Sideris, Margaritis Avgeris, Vassilios Zoumpourlis, Ioannis Michalopoulos & Nikolaos Drakoulis. (2023) miRNA-Based Technologies in Cancer Therapy. Journal of Personalized Medicine 13:11, pages 1586.
Crossref
Ji-In Seo, Chikako Nishigori, Jung Jin Ahn, Jae Young Ryu, Junglok Lee, Mu-Hyoung Lee, Su Kang Kim & Ki-Heon Jeong. (2023) Whole Exome Sequencing of a Patient with a Milder Phenotype of Xeroderma Pigmentosum Group C. Medicina 59:4, pages 699.
Crossref
Aaron Curtis, Yajun Yu, Megan Carey, Patrick Parfrey, Yildiz E. Yilmaz & Sevtap Savas. (2022) Examining SNP-SNP interactions and risk of clinical outcomes in colorectal cancer using multifactor dimensionality reduction based methods. Frontiers in Genetics 13.
Crossref
Marina Emelyanova, Ilya Pokataev, Igor Shashkov, Elena Kopantseva, Vladimir Lyadov, Rustam Heydarov & Vladimir Mikhailovich. (2021) TYMS 3′-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients. Pharmaceutics 14:1, pages 77.
Crossref
Alexandr N. Chernov, Diana A. Alaverdian, Elvira S. Galimova, Alessandra Renieri, Elisa Frullanti, Ilaria Meloni & Olga V. Shamova. (2021) The phenomenon of multidrug resistance in glioblastomas. Hematology/Oncology and Stem Cell Therapy.
Crossref
Eneida Turiján-Espinoza, Víctor Manuel Ruíz-Rodríguez, Edith Elena Uresti-Rivera, Ernesto Martínez-Leija, José de Jesús Zermeño-Nava, Arturo Guel-Pañola, Silvia Romano-Moreno, Juan Manuel Vargas-Morales & Diana Patricia Portales-Pérez. (2021) Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Cancer Chemotherapy and Pharmacology 87:6, pages 843-853.
Crossref
Mourad A.M. Aboul-Soud, Alhussain J. Alzahrani & Amer Mahmoud. (2021) Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing. Saudi Journal of Biological Sciences 28:1, pages 628-634.
Crossref
Emma C. Hulshof, Lifani Lim, Ignace H. J. T. de Hingh, Hans Gelderblom, Henk-Jan Guchelaar & Maarten J. Deenen. (2020) Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review. Frontiers in Pharmacology 11.
Crossref
Lucia Borszéková Pulzová, Thomas A. Ward & Miroslav Chovanec. (2020) XPA: DNA Repair Protein of Significant Clinical Importance. International Journal of Molecular Sciences 21:6, pages 2182.
Crossref
Yiyi Zhang, Lijun Sun, Xiaojie Wang, Yanwu Sun, Ying Chen, Meifang Xu, Pan Chi, Xingrong Lu & Zongbin Xu. (2020) FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis. Frontiers in Genetics 11.
Crossref
Yan-Ke Li, Qian Xu, Li-Ping Sun, Yue-Hua Gong, Jing-Jing Jing, Cheng-Zhong Xing & Yuan Yuan. (2020) Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer. World Journal of Gastroenterology 26:3, pages 307-323.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.